B Cell lymphoma vaccine (Genitope)

N/A

Report date: 2024/05/02 20:00:03

Base Information

Drug NameB Cell lymphoma vaccine (Genitope)
Drug Alias NameB细胞淋巴瘤疫苗 - GenitopeMyVaxglut/Id-KLHGTOP-99Id-KLH
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMultiple MyelomaLymphoma, Non-HodgkinLymphoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenitope
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenitope CorporationFavrille IncUniversity Of Washington Cancer Consortium
Active IndicationsN/A
Inactive IndicationsMultiple MyelomaLymphoma, Non-HodgkinLymphoma +[4] 

Other Information

ATC CodeN/A
Related LinksN/A